Literature DB >> 16181080

Regulation of endothelial cell death and its role in angiogenesis and vascular regression.

Kazuhiro Sakamaki1.   

Abstract

In multicellular organisms, apoptosis, also known as programmed cell death, is an important physiological response to eliminate unnecessary, excess, or harmful cells. Apoptosis occurs during embryonic development and is important in maintaining homeostasis during adulthood. Apoptosis also plays critical roles in angiogenesis and vessel regression. During these processes, activation of the apoptotic signaling pathway in endothelial cells mediates cell death. Several molecules, including growth factors and cytokines, produced by endothelial cells and other cells, regulate endothelial cell survival and apoptosis. Understanding the regulation of apoptosis is of great importance for determining the physiological role of endothelial cells and for developing novel therapeutic strategies. This review highlights the rapidly accumulating knowledge regarding endothelial cell death and provides insight into the molecular mechanisms regulating apoptosis and survival of endothelial cells.

Mesh:

Substances:

Year:  2004        PMID: 16181080     DOI: 10.2174/1567202043362072

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  18 in total

1.  Opposing effects of bim and bcl-2 on lung endothelial cell migration.

Authors:  Cathy Grutzmacher; SunYoung Park; Tammy L Elmergreen; Yixin Tang; Elizabeth A Scheef; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

2.  A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction on endothelial cells.

Authors:  Jun Song; Wen-Yuan Chen; Li-Ya Wu; Liang-Pu Zheng; Wei Lin; Dong Gao; Ted J Kaptchuk; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

Review 3.  Winding through the WNT pathway during cellular development and demise.

Authors:  F Li; Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2006-01       Impact factor: 2.303

Review 4.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 5.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

6.  Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB.

Authors:  Faqi Li; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2006-08       Impact factor: 1.990

7.  Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

Authors:  Michael H Davies; David O Zamora; Justine R Smith; Michael R Powers
Journal:  Microvasc Res       Date:  2009-02-13       Impact factor: 3.514

8.  CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.

Authors:  An-Chi Tsai; Shiow-Lin Pan; Hui-Lung Sun; Chih-Ya Wang; Chieh-Yu Peng; Shih-Wei Wang; Ya-Ling Chang; Sheng-Chu Kuo; Kuo-Hsiung Lee; Che-Ming Teng
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

9.  Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo.

Authors:  Lingdong Li; Chuanjiang Yu; Jiang Ren; Sujuan Ye; Wenjing Ou; Yu Wang; Weihan Yang; Guoxing Zhong; Xiang Chen; Huashan Shi; Xiaolan Su; Lijuan Chen; Wen Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

10.  MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Michael R Powers
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.